Clinical pharmacokinetics of hydrallazine.
D000107:Acetylation; D000818:Animals; D001682:Biological Availability; D005260:Female; D006207:Half-Life; D006801:Humans; D006830:Hydralazine / Q000009:adverse effects / Q000378:metabolism* / Q000652:urine; D006973:Hypertension / Q000378:metabolism; D007676:Kidney Failure, Chronic / Q000378:metabolism; D008099:Liver / Q000378:metabolism; D008180:Lupus Erythematosus, Systemic / Q000139:chemically induced; D008297:Male; D011485:Protein Binding
D006830:Hydralazine